{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:35:15Z","timestamp":1782783315607,"version":"3.54.5"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0219526","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:35:08Z","timestamp":1562866508000},"page":"e0219526","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-3347","authenticated-orcid":true,"given":"Leona","family":"Dold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette J.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Praktiknjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolynne","family":"Schwarze-Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Boesecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Christian","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7700-2915","authenticated-orcid":true,"given":"Jenny","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen Kurt","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-3881","authenticated-orcid":true,"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana J.","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"ref1","first-page":"1198","article-title":"Increasing burden of liver disease in patients with HIV infection","volume":"377","author":"D Joshi","year":"2011"},{"key":"ref2","first-page":"1537","article-title":"Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study","volume":"24","author":"C Smith","year":"2010"},{"key":"ref3","article-title":"Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan","author":"CC Chou","year":"2014"},{"key":"ref4","first-page":"1708","article-title":"Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection","volume":"362","author":"N Qurishi","year":"2003"},{"key":"ref5","first-page":"118","article-title":"Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients","volume":"10","author":"C Tural","year":"2003"},{"key":"ref6","first-page":"2","article-title":"Microbial translocation in the pathogenesis of HIV infection and AIDS","volume":"26","author":"G Marchetti","year":"2013"},{"key":"ref7","first-page":"218","article-title":"Lipid Abnormalities and Inflammation in HIV Inflection","volume":"13","author":"NT Funderburg","year":"2016"},{"key":"ref8","first-page":"195","article-title":"Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats","volume":"4","author":"R Schierwagen","year":"2013"},{"key":"ref9","first-page":"2081","article-title":"Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers","volume":"28","author":"DJ Leeming","year":"2014"},{"key":"ref10","first-page":"e108544","article-title":"PRO-C3-levels in patients with HIV\/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension","volume":"9","author":"C Jansen","year":"2014"},{"key":"ref11","first-page":"429","article-title":"Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C","volume":"35","author":"MJ Nielsen","year":"2015"},{"key":"ref12","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"MJ Nielsen","year":"2013"},{"key":"ref13","first-page":"482","article-title":"Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis","volume":"42","author":"DJ Leeming","year":"2012"},{"key":"ref14","first-page":"49","article-title":"Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type iii, in a rat model of reversible carbon-tetrachloride-induced fibrosis","volume":"6","author":"E Vassiliadis","year":"2011"},{"key":"ref15","first-page":"e84934","article-title":"MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis\u2014validation of two novel biomarker assays","volume":"8","author":"JM Sand","year":"2013"},{"key":"ref16","first-page":"13","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan","volume":"36","author":"M Sasso","year":"2012"},{"key":"ref17","first-page":"902","article-title":"Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography","volume":"32","author":"RP Myers","year":"2012"},{"key":"ref18","first-page":"e91987","article-title":"Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy","volume":"9","author":"T Karlas","year":"2014"},{"key":"ref19","first-page":"1022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"T Karlas","year":"2017"},{"key":"ref20","first-page":"343","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"L Castera","year":"2005"},{"key":"ref21","first-page":"403","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study","volume":"55","author":"J Foucher","year":"2006"},{"key":"ref22","first-page":"518","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"CT Wai","year":"2003"},{"key":"ref23","first-page":"183","article-title":"Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)","volume":"14","author":"E Rosenthal","year":"2007"},{"key":"ref24","first-page":"183","article-title":"Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons","volume":"8","author":"N Crum-Cianflone","year":"2010"},{"key":"ref25","first-page":"1392","article-title":"Prevalence and characteristics of pain induced by percutaneous liver biopsy","volume":"96","author":"E Eisenberg","year":"2003"},{"key":"ref26","first-page":"15","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group","volume":"20","year":"1994"},{"key":"ref27","first-page":"135","article-title":"Usefulness of elastometry in evaluating the extents of liver fibrosis in hemophiliacs coinfected with hepatitis C virus and human immunodeficiency virus","volume":"35","author":"N Masaki","year":"2006"},{"key":"ref28","first-page":"211","article-title":"Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis","volume":"2","author":"M Praktiknjo","year":"2018"},{"key":"ref29","first-page":"287","article-title":"Antiretroviral therapy hepatotoxicity: Prevalence, risk factors, and clinical characteristics in a cohort of Han Chinese","volume":"40","author":"S Gao","year":"2010"},{"key":"ref30","first-page":"e0191118","article-title":"Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients","volume":"13","author":"E Anadol","year":"2018"},{"key":"ref31","first-page":"e0462","article-title":"Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis","volume":"97","author":"R Mohr","year":"2018"},{"key":"ref32","first-page":"885","article-title":"Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis","volume":"39","author":"J Lehmann","year":"2019"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0219526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:53:40Z","timestamp":1589018020000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0219526"}},"subtitle":[],"editor":[{"given":"Matias A","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0219526","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}